Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 51655-368

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 51655-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 368 52 Master Bottle Label Approval Rev A 06 20)

Label for Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, oral dosage form. The container holds 30 tablets and is labeled for prescription use only. The label includes the product NDC 51655-368-52 and indicates repackaging by Northwind Pharmaceuticals. Storage and dosage instructions are referenced to the package insert.*

FDA Label Image

Chemical Structure (Metformin 01)

Chemical structure diagram of metformin hydrochloride showing its molecular composition and arrangement, consistent with the active ingredient in the product Metformin Hydrochloride 750 mg extended release tablets by Northwind Health Company.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.